Skip to main content

Table 1 Size of FLT3 inhibitor conjugated GNP measured by DLS and PdI, their zeta potential together with zeta deviation, LSPR position, and calculated drug loading efficiency

From: Design of FLT3 Inhibitor - Gold Nanoparticle Conjugates as Potential Therapeutic Agents for the Treatment of Acute Myeloid Leukemia

Sample Zeta potential (mV) Zeta deviation (mV) Diameter (nm) Polydispersity index (PdI) LSPR position (nm) Loading efficiency (%)
GNP −44 ± 2 5 ± 1 17 ± 2 0.45 519
GNP-PL −25 ± 2 10 ± 1 30 ± 1 0.54 520
GNP-MDS-PL −20 ± 1 9.8 ± 1 58 ± 2 0.46 529 80
GNP-SRF-PL −17.5 ± 0 .5 7.8 ± 3 48 ± 1 0.52 526 10
GNP-QZR-PL −5 ± 0.7 4 ± 0.2 58 ± 2 0.53 523 8
GNP-LST-PL −10 ± 0.5 8.5 ± 0.3 44 ± 2 0.95 527 10